| Date Filed | Type | Description |
| 02/23/2023 |
4
| Zeldin Robert K (CHIEF MEDICAL OFFICER) has filed a Form 4 on MeiraGTx Holdings plc|
Txns:
| Granted 30,000 options to buy
@ $8.6, valued at
$258k
Granted 30,000 options to buy
@ $0 |
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2022 |
4
| Zeldin Robert K (Chief Medical Officer) has filed a Form 4 on MeiraGTx Holdings plc|
Txns:
| Granted 30,000 options to buy
@ $21.53, valued at
$645.9k
Granted 70,000 options to buy
@ $0 |
|
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/20/2019 |
4
| Zeldin Robert K (Chief Medical Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 380,325 options to buy
@ $7.86, valued at
$3M
|
|
| 12/20/2019 |
3
| Zeldin Robert K (Chief Medical Officer) has filed a Form 3 on Immunovant, Inc. |
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2018 |
4
| Zeldin Robert K (EVP & Chief Medical Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 16,903 shares
@ $0
Granted 85,511 options to buy
@ $47.33, valued at
$4M
|
|
| 07/05/2018 |
3
| Zeldin Robert K (EVP & Chief Medical Officer) has filed a Form 3 on ACCELERON PHARMA INC |